PharmaTimes May 22, 2024
Jen Brogan

The nanocage technology combines both mRNA and traditional virus-based vaccines to create virus-like efficacious vaccines

A new technology developed by researchers from King’s College London (KCL) could provide a new way of delivering drugs to advance next-generation treatments to prevent and treat a variety of diseases.

Published in the nanotechnology journal Small, the ‘plug and play’ technology could also lead to new therapeutics that act as both a vaccine and a drug, preventing disease and symptoms.

For over two decades, a common protein called ferritin, which manages iron in all organisms, has been used to create vaccines and deliver anticancer drugs, as well as other medicines, to the body.

Until now, scientists have been unable to develop a universal approach...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID
Opinion: The FDA needs to embrace phage therapy to help fight antimicrobial resistance
Timothy Garvey, MD: Drivers of Differences in Weight Loss with Incretins Based on Diabetes Status
J&J acquires immune disease biologics company for $850M
FDA Approves Sarepta Gene Therapy, But Only After Top FDA Official Bucks Agency Staff
Chimps’ self-medication with plants could aid drug discovery

Share This Article